CLINE CHRISTOPHER R. (CHIEF FINANCIAL OFFICER) sold 36.6% of their position (50.51K shares) of TRAVERE THERAPEUTICS, INC. on the open market
Open‑market sale worth $3.15M — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
Common Stock
Shares
+20K
Price / share
$17.44
Trade value
$348.80K
% of position
Common Stock
Shares
−27.47K
Price / share
$62.00
Trade value
$1.70M
% of position
Common Stock
Shares
−20.73K
Price / share
$62.61
Trade value
$1.30M
% of position
Common Stock
Shares
−1.90K
Price / share
$63.69
Trade value
$121K
% of position
Common Stock
Shares
−400.00
Price / share
$65.31
Trade value
$26.12K
% of position
Net shares
−30.51K
Net value
-$2.80M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 9/15/2026 | M · Option Exercise | +20K | $17.44 | $348.80K | 16.9% | 118.02K | 138.02K |
| Common Stock Direct | 9/15/2026 | S · Sale | −27.47K | $62.00 | $1.70M | 19.9% | 138.02K | 110.54K |
| Common Stock Direct | 9/15/2026 | S · Sale | −20.73K | $62.61 | $1.30M | 18.8% | 110.54K | 89.81K |
| Common Stock Direct | 9/15/2026 | S · Sale | −1.90K | $63.69 | $121K | 2.1% | 89.81K | 87.91K |
| Common Stock Direct | 9/15/2026 | S · Sale | −400.00 | $65.31 | $26.12K | 0.5% | 87.91K | 87.51K |
| Total | −30.51K | -$2.80M | ||||||
Employee stock option (right to buy)
Common Stock
20K shares
Shares
−20K
Strike price
17.44
Held after
0.00
Exercisable
—
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Employee stock option (right to buy) Direct | Common Stock20K shares | 9/15/2026 | M · Option Exercise | −20K | 17.44 | — | 0.00 |